Skip to content

Cigna CI Cash & Equivalents

Cash & Equivalents at other companies

Humana logo
HumanaHUM
$6.89B+70.6%
CVS Health logo
CVS HealthCVS
$9.77B-5.6%
UnitedHealth Group logo
UnitedHealth GroupUNH
$28B-8.8%
Option Care Health, Inc. logo
Option Care Health, Inc.OPCH
$193.77M-2.5%
Elevance Health logo
Elevance HealthELV
$10.23B+19.5%
Teladoc Health logo
Teladoc HealthTDOC
$774.35M+13.9%

Other financials

Income statement

See full
Revenue$71.7B+6.7%
Gross profit$15.0B+7.6%
Operating income$2.7B+16.0%
Net income$1.7B+1.7%
EPS (diluted)$6.29+10.2%

Balance sheet

See full
Total debt$31.9B
Total equity$42.6B+6.0%
Total assets$157.08B+3.6%

Cash flow

See full
Operating cash flow$1.1B-41.1%

Valuation

See full
Market cap$78.43B-1.4%
Enterprise value$104.01B
P/E12.6×-2.1×
P/S0.3×0.0×

Profitability

See full
Gross margin20.6%-3.7pp
Operating margin3.5%+0.1pp
Net margin2.2%+0.1pp
FCF margin5.5%

Returns & leverage

See full
Return on equity15%+1.8pp
Debt / equity0.7×
Current ratio0.8×+0.1×

Where this comes from

Reported directly by Cigna in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The official record: Cigna’s 10-Q, filed July 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cigna's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cigna's cash & equivalents?
Cigna (CI) reported cash & equivalents of $6.3B in Q2 2026.
How has Cigna's cash & equivalents changed year-over-year?
Cigna's cash & equivalents increased by 45.5% year-over-year, from $4.33B to $6.3B.
What is the long-term trend for Cigna's cash & equivalents?
Over 5 years (2020 to 2025), Cigna's cash & equivalents has grown at a -5.5% compound annual growth rate (CAGR), from $10.18B to $7.68B.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.